HIV Glasgow 2024

HIV Glasgow 2024

Fox D, et al.

Treatment‐emergent integrase strand transfer inhibitor (INSTI) resistance‐associated mutations among people living with HIV‐1 treated with dolutegravir (DTG) + lamivudine (3TC) with pre‐existing M184V/I from real‐world and interventional studies

HIV_Glasgow24_P08_2024-11-01
Video Player is loading.
Current Time 0:00
Duration 4:20
Loaded: 0%
Stream Type LIVE
Remaining Time 4:20
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Navigate to: